TherapeuticsMD And 2 Other Stocks Under $2 Executives Are Buying
TherapeuticsMD And 2 Other Stocks Under $2 Executives Are Buying
TherapeuticsMD和其他2只股票低於2美元，高管正在買入
The Dow Jones index closed higher by more than 450 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
道瓊斯指數週五收高逾450點。當內部人購買或賣出股票時，這表明他們對公司前景的信心或擔憂。對於對低價股感興趣的投資者和交易者，可以考慮這一因素來決定他們的全面投資或交易決策。
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
以下是幾個近期關於低價股的值得關注的內部交易。了解更多，請查看Benzinga內幕交易平台。
System1
System1
- The Trade: System1, Inc. (NYSE:SST) 10% owner Cee Holdings Trust bought a total of 46,373 shares at an average price of $1.22. To acquire these shares, it cost around $56,378.
- What's Happening: On Aug. 8, System1 posted upbeat quarterly earnings.
- What System1 Does: System1 Inc develops technology and data science to operate a responsive acquisition marketing platform.
- 交易：System1, Inc.（紐交所：SST）的10％持有者Cee Holdings Trust以平均價格1.22美元購買了46373股。要獲得這些股票，花費了約56378美元。
- 正在發生什麼：8月8日，System1發佈了樂觀的季度收益報告。
- System1 Inc開發技術和數據科學，以運營響應式收購營銷平台。
TherapeuticsMD
therapeuticsmd
- The Trade: TherapeuticsMD, Inc. (NASDAQ:TXMD) Director Cooper C. Collins acquired a total of 1,200 shares at an average price of $1.70. To acquire these shares, it cost around $2,039.
- What's Happening: On Aug. 12, TherapeuticsMD posted a second-quarter loss of 9 cents per share.
- What TherapeuticsMD Does: TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories.
- 交易：TherapeuticsMD, Inc.（納斯達克：TXMD）的董事Cooper C. Collins以平均價格1.70美元購買了1200股。要獲得這些股票，花費了約2039美元。
- 最新動態：therapeuticsmd在8月12日發佈了每股9美分的第二季度虧損。
- therapeuticsmd的業務：therapeuticsmd公司是一家藥品特許費公司，目前收取對掌握相關領土商業能力的藥品組織許可產品的特許費。
Ault Alliance
奧特聯盟
- The Trade: Ault Alliance, Inc. (NYSE:AULT) Executive Chairman Milton C Ault III acquired a total of 2,800 shares at an average price of $0.23. The insider spent around $655 to buy those shares.
- What's Happening: On Aug. 20, Ault Alliance declared a monthly cash dividend of $0.2708333 Per Share of 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock.
- What Ault Alliance Does: Ault Alliance Inc is a diversified holding company. It operates a data center at which it mines Bitcoin and provides mission-critical products that support a diverse range of industries, including oil exploration, crane services, defense/aerospace, industrial, automotive, medical/biopharma, consumer electronics, hotel operations and textiles.
- 這次交易：Ault Alliance公司（NYSE：AULT）的執行主席Milton C Ault III以每股0.23美元的平均價格收購了2800股，這位內部人士花了大約655美元買入這些股票。
- 最新動態：8月20日，Ault Alliance宣佈每股13.00%D系列永續可贖回優先股的月度現金股息爲0.2708333美元。
- Ault Alliance的業務：Ault Alliance公司是一家多元化控股公司。它在一個數據中心運營，進行比特幣挖掘，並提供支持多種行業的關鍵產品，包括石油勘探、起重機服務、國防/航空航天、工業、汽車、醫療/生物製藥、消費電子-半導體、酒店運營和紡織品。
- Jim Cramer Praises L3Harris Technologies, Says Intel Is 'Getting Whacked' By AMD: 'I Much Prefer...'
- 吉姆·克拉默讚揚l3harris technologies，稱英特爾正在受到AMD的打擊：'我更喜歡......'
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間